| Document Date: 2009-03-31 14:54:05
Open Document File Size: 236,36 KBShare Result on Facebook
Company Ames / / Event Product Issues / / Facility Laboratory Tests / Laboratory Tests In general / / IndustryTerm chemical designation / / MedicalCondition venous and arterial thromboembolism / Serious anaphylactic reactions / uncontrolled hypertension / ischemic stroke / shock / Carcinogenesis / marked renal insufficiency / deep venous thrombosis / cerebrovascular accident / stroke / thrombocytopenia / anaphylaxis / heparin-associated thrombocytopenia / renal insufficiency / myocardial infarction / allergic reactions / liver cirrhosis / pulmonary embolism / hypersensitivity / anaphylactic reactions / thromboembolic disease / Liver Injury / Serious liver injury / Bacterial endocarditis / Hemorrhagic diathesis / / MedicalTreatment thrombolytic therapy / major surgery / hemodialysis / amputation / surgery / / Organization REFLUDAN administration / World Health Organization / DOSAGE AND ADMINISTRATION / / Position treating physician / General / / Product REFLUDAN / Sodium Chloride / vitamin K / mannitol / Sterile Water for Injection / patients / / Technology DNA synthesis / Antibodies / /
SocialTag |
Prescribing Information as of October, 2004 REFLUDAN® [lepirudin (rDNA) for injection]